Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 1:20 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 88 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Surveillance Visit Clear all

Conditions: Thyroid Cancer, Thyroid, Refractory Thyroid Cancer
Interventions: Surveillance Visit; Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Breast Cancer Survivorship
Interventions: Adapted Patient Priorities Care (PPC) approach, Usual Care; Behavioral · Other
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 65 Years to 100 Years · Female only
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 3
States / cities: Bellaire, Texas • Houston, Texas

Conditions: Gastroesophageal Reflux, Fundoplication, Hernia, Hiatal, Surveys and Questionnaires
Interventions: Mayo Clinic Foregut Surgery Report Card Questionnaire; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 274 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Intermediate Risk Non-Muscle Invasive Bladder Cancer
Interventions: Nadofaragene Firadenovec; Drug
Lead sponsor: Ferring Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 454 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2032
U.S. locations: 55
States / cities: Mobile, Alabama • Phoenix, Arizona • Tucson, Arizona + 49 more

Conditions: Literacy, Child Development, Parenting
Interventions: Rx for Success Smartphone Application, Control - screen time reduction; Other
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 6 Months to 21 Months
Enrollment: 252 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Medication Adherence
Interventions: EMC2; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 301 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Influenza
Interventions: Pasteurized milk contaminated with killed A(H5) virus; Other
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 64 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Hiv, Sexually Transmitted Infection
Interventions: SNAPS intervention; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: Prostate Cancer
Interventions: eVisit; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older · Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 4
States / cities: Cary, North Carolina • Durham, North Carolina • Raleigh, North Carolina

Conditions: Hiv
Interventions: Data to Suppression (D2S), Usual practice; Other
Lead sponsor: City University of New York; Other
Eligibility: Not listed
Enrollment: 1,494 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 27
States / cities: New York, New York

Conditions: Hypertensive Disorder of Pregnancy
Interventions: Remote Patient Monitoring; Device
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 213 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Shwachman-Diamond Syndrome
Interventions: Oral Glucose Tolerance Test, Modified Oral Glucose Tolerance Test, Modified Mixed Meal Tolerance Test, Continuous Glucose Monitor, Food Diary, Medical History Questionnaires; Diagnostic Test · Other · Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 3 Years and older
Enrollment: 11 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Prostate Cancer
Interventions: Lower-Carbohydrate Med-t-Diet, Low-Fat Med-t-Diet; Other
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 18 Years and older · Male only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Breast Cancer, Prostate Cancer, Patient Engagement, Patient Preference, Patient Satisfaction
Interventions: FOLLOW UP VISIT-TELEMEDICINE, FOLLOW UP VISIT-FACE TO FACE; Behavioral
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Multiple Sclerosis
Interventions: Not listed
Lead sponsor: Biogen; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 383 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2017
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Breast Cancer, Breast Cancer Female
Interventions: Blood test; Diagnostic Test
Lead sponsor: Immunis.AI; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Bladder Cancer
Interventions: Hexaminolevulinate hydrochloride, KARL STORZ D-Light C PDD Flexible Videoscope System; Drug · Device
Lead sponsor: Photocure; Industry
Eligibility: 18 Years and older
Enrollment: 304 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 17
States / cities: Los Angeles, California • Chicago, Illinois • Iowa City, Iowa + 12 more

Conditions: Breast Cancer
Interventions: MOve-ABC, Enhanced Usual Care; Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Motor Delay, Infant Development, Motor Development of Premature Infants, Motor Coordination or Function; Developmental Disorder
Interventions: Not listed
Lead sponsor: Shirley Ryan AbilityLab; Other
Eligibility: 0 Days to 52 Weeks
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Endometrial Cancer Survivors, Weight Management, Early Stage Endometrial Cancer
Interventions: Weight loss with pharmacotherapy, Weight loss without pharmacotherapy; Behavioral
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Hypertension in Pregnancy
Interventions: Home Blood Pressure Telemonitoring; Device
Lead sponsor: University of Mississippi Medical Center; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Jackson, Mississippi

Conditions: Prostate Cancer
Interventions: Personalized risk model+website+coaching intervention; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older · Male only
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 2
States / cities: San Francisco, California

Conditions: Active Surveillance, Clear Cell Renal Cell Carcinoma
Interventions: Belzutifan, Active Surveillance; Drug · Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Osteoarthritis, Hip, Hip Disease, Hip Osteoarthritis, Joint Pain
Interventions: Wright Medical Technology Metal-on-Metal Total Hip System; Device
Lead sponsor: MicroPort Orthopedics Inc.; Industry
Eligibility: 21 Years and older
Enrollment: 173 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 4
States / cities: El Cajon, California • La Mesa, California • Iowa City, Iowa + 1 more

Search by objective public record fields.

A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer

Patient Priorities for Survivorship Care in Older Breast Cancer Survivors

Mayo Clinic Foregut Surgery Report Card Questionnaire

Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

Rx for Success: RCT of an App for Dialogic Reading Training

Development and Evaluation of an Electronic Health Record-based Medication Complete Communication (EMC2) Strategy

H5N1 Milk Detection Study

Expanding PrEP By Embedding Unannounced SNAPS Navigators in High STI Testing Clinical Sites

Electronic Post-Treatment Surveillance Program for Prostate Cancer Survivors (eHealth)

Testing a Novel Data-to-Suppression (D2S) Intervention Strategy in the Ryan White HIV/AIDS Program

Remote BP Monitoring in the PP Period

Diabetes/ Endocrine Surveillance in SDS

Metabolic Impact of Prospective Controlled Mediterranean Type Diets on Prostate Cancer

TIPOPS (Telemedicine vs In Person Oncology Patient Surveillance)

Controlled High Risk AVONEX® Multiple Sclerosis Prevention Study In Ongoing Neurological Surveillance

SNAPS Breast Cancer Patient Study Breast Cancer Patients

A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting

Breast Cancer Pre-habilitation and Prospective Surveillance to Prevent, Detect, and Optimize Physical and Function

Wearable Sensor Toolkit for Infant Motor Development

Weight Loss Management in Endometrial Cancer Survivors

STAMPP-HTN in a High-risk Rural Population of Women

Decision Support Tools for Men With Prostate Cancer- Clinical & Lifestyle Model

Belzutifan's Role in Active Surveillance Versus Treatment for Indolentmetastatic Clear Cell Renal Ccell Carcinoma (BRAVE-RCC)

Wright Medical Technology Metal-on-Metal 522 Post-Market Surveillance Study